Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.
OBJECTIVE
The purpose of this study was to determine the association of maternal psychotropic medication use during pregnancy with preterm delivery and other adverse perinatal outcomes.


METHODS
A cohort of 2793 pregnant women in Washington State was interviewed, and their medical files were abstracted. Logistic regression models were constructed to assess odds ratios for perinatal outcomes by use of psychotropic medications.


RESULTS
Maternal use of benzodiazepine during pregnancy was associated with an increased risk of preterm delivery (adjusted odds ratio, 6.79; 95% confidence interval, 4.01-11.5) and with increased risks of low birthweight, low Apgar score, neonatal intensive care unit admissions, and respiratory distress syndrome. Selective serotonin receptor inhibitors were associated with preterm deliveries only among women who started treatment after the first trimester.


CONCLUSIONS
Benzodiazepine was associated highly with preterm delivery and other adverse perinatal outcomes. Well-conducted cohort studies are warranted to draw conclusions about risks and benefits of psychotropic medication use during pregnancy.
Calderon-Margalit
Ronit
R
Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA 98101, USA. ronitc@u.washington.edu
Qiu
Chunfang
C
Ornoy
Asher
A
Siscovick
David S
DS
Williams
Michelle A
MA
D000328:Adult; D001569:Benzodiazepines / Q000009:adverse effects; D015331:Cohort Studies; D005260:Female; D006801:Humans; D016015:Logistic Models; D016017:Odds Ratio; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000139:chemically induced*; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012307:Risk Factors; D012702:Serotonin Antagonists / Q000009:adverse effects
D011619:Psychotropic Drugs; D012702:Serotonin Antagonists; D001569:Benzodiazepines
JAMA. 2005 May 18;293(19):2372-83
15900008
Am J Psychiatry. 2002 Dec;159(12):2055-61
12450956
Am J Epidemiol. 2002 Feb 15;155(4):293-301
11836191
J Clin Psychopharmacol. 2007 Dec;27(6):607-13
18004128
Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8
17216624
Br J Clin Pharmacol. 2008 Nov;66(5):695-705
18754846
Lancet. 2008 Jan 19;371(9608):261-9
18207020
Obstet Gynecol. 2008 Apr;111(4):1001-20
18378767
N Engl J Med. 1996 Oct 3;335(14):1010-5
8793924
J Epidemiol Community Health. 2003 Aug;57(8):565-70
12883057
Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):232-235
15014590
Health Psychol. 2008 Jan;27(1):43-51
18230013
Lancet. 2008 Jan 5;371(9606):75-84
18177778
BJOG. 2007 Sep;114(9):1055-64
17565615
Am J Obstet Gynecol. 2006 Apr;194(4):961-6
16580283
Reprod Toxicol. 1998 Sep-Oct;12(5):511-5
9763242
Eur J Clin Pharmacol. 2006 Oct;62(10):863-70
16896784
Arch Womens Ment Health. 2005 Sep;8(3):181-9
15959623
Br J Psychiatry. 2008 May;192(5):338-43
18450656
Am J Obstet Gynecol. 2008 Feb;198(2):194.e1-5
17905176
Pediatrics. 2007 Jan;119(1):52-9
17200271
Reprod Toxicol. 1994 Nov-Dec;8(6):461-75
7881198
Lancet Neurol. 2005 Aug;4(8):465-75
16033689
Ann Epidemiol. 1997 Nov;7(8):568-74
9408553
Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1203-10
17894421
Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6
15066868